Medicare Advantage–Pharmacy Partnership Improves Influenza and Pneumococcal Vaccination Rates

AJMC October 13, 2021
Richard L. Sheer, BA, David P. Nau, PhD, Nicholas Dorich, PharmD, Jesse McCullough, PharmD, Annette D. Boyer, RPh, Matthew Pickering, PharmD, Patrick J. Campbell, PharmD, PhD, Margaret K. Pasquale, PhD

Patients whose pharmacy receives notification of their immunization gap have twice the odds of receiving immunizations compared with those whose pharmacy does not receive the notification.

ABSTRACT

Objectives: To evaluate the impact of a collaborative effort of a Medicare Advantage and prescription drug (MAPD) plan and community pharmacies to improve vaccination rates for pneumonia and influenza.

Study Design: This quasiexperimental, cluster-randomized intervention study used MAPD data to assess the impact of community pharmacists on vaccination rates. Pharmacies in specific regions (districts) were randomly assigned to intervention or control groups. Intervention pharmacies received reports of patients with a gap in influenza (aged 19-89 years) and/or pneumococcal (aged 65-89 years) vaccinations based on medical and pharmacy claims history. Vaccine-naïve patients were offered...

Today's Sponsors

Today's Sponsor